Total oligomeric flavonoids of Cyperus rotundus ameliorates neurological deficits, excitotoxicity and behavioral alterations induced by cerebral ischemic-reperfusion injury in rats

Brain Research Bulletin

Volumn 84, Issue 6, 2011, Pages 394-405

  Sunil, A G ^a   Kesavanarayanan, K S ^a   Kalaivani, P ^a   Sathiya, S ^a   Ranju, V ^a   Priya, R Jyothi ^a   Pramila, B ^a   Paul, F D Solomon ^a   Venkhatesh, J ^a   Babu, C Saravana ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Behavior; Cerebral stroke; Cyperus rotundus; Excitotoxicity; Middle cerebral artery occlusion (MCAO); Total oligomeric flavonoids

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYPERUS ROTUNDUS EXTRACT; FLAVONOID; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN ISCHEMIA; BRAIN PROTECTION; COGNITION; CONTROLLED STUDY; CYPERUS ROTUNDUS; ENZYME ACTIVITY; EXCITOTOXICITY; HISTOPATHOLOGY; MEDICINAL PLANT; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CYPERUS; FLAVONOIDS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MALONDIALDEHYDE; MEDICINE, AYURVEDIC; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 79953033934     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.01.008     Document Type: Article

References (46)

1. Aissouni L.H., Re D.B., Nieoullon A., Le Goff L.K. Importance of astrocytes inactivation of synaptically released glutamate for cell survival in the central nervous system - are astrocytes vulnerable to low intracellular glutamate concentration?. J. Physiol. 2002, 96:317.
2. Alexis N.E., Dietrich W.D., Green E.J., Prado R., Watson B.D. Non-occlusive common carotid artery thrombosis in the rat results in reversible sensorimotor and cognitive behavioral deficits. Stroke 1995, 26:2338-2346.
3. Babu C.S., Ramanathan M. Pre-ischemic treatment with memantine reversed the neurochemical and behavioural parameters but not energy metabolites in middle cerebral artery occluded rats. Pharmacol. Biochem. Behav. 2009, 92:424-432.
4. Babu C.S., Sunil A.G., Vasanthi H.R., Ramanathan M., Muthusamy V.S. Development and validation of an HPTLC method for simultaneous estimation of excitatory neurotransmitters in rat brain. J. Liq. Chromatogr. Relat. Technol. 2007, 30:1-12.
5. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 2005, 80:1326-1338.
6. Block F., Schwarz M. Dextromethorphan reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res. 1996, 741:153-159.
7. Carlo D. Human and economic burden of stroke. Age Ageing 2009, 38:4-5.
8. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
9. Engin E., Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav. Pharmacol. 2007, 18:365-374.
10. Freeman B.A., Carpo J.D. Biology of disease, free radicals and tissue injury. Lab Invest. 1982, 47:412-426.
11. Hattori K., Lee H., Hurn P.D., Crain B.J., Richard J., Traystman A., DeVries C., Lyeth B.G. Cognitive deficits after focal cerebral ischemia in mice. Stroke 2000, 31:1939-1944.
12. Hoyte L., Kaur J., Buchan A.M. Lost in translation: taking neuroprotection from animal models to clinical trials. Exp. Neurol. 2004, 188:200-204.
13. Jollow D.J., Mitchell J.R., Zampaglione N., Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene as the hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
14. Jortner B.S. Neuropathological assessment in acute neurotoxic states. The "Dark" neuron. J. Med. CBR Def. 2005, 3:1-5.
15. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 1984, 21:130-132.
16. Keli S.O., Hertog M.G., Feskens E.J., Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch. Intern. Med. 1996, 156:637-642.
17. Kilani S., Sghaier M.B., Limem I., Bouhlel I., Boubaker J., Bhouri W., Skandrani I., Neffatti A., Ammar R.B., Franca M.G.D., et al. In vitro evaluation of antibacterial, antioxidant, cytotoxic and apoptotic activities of the tubers infusion and extracts of Cyperus rotundus. Bioresour. Technol. 2008, 99:9004-9008.
18. Kilani S.J., Neffati A., Limem I., Boubaker J., Skandrani I., Sghair M.B., Bouhlel I., Bhouri W., Mariotte A.M., Ghedira K., Franca M.G.D., Ghedir L.C. Relationship correlation of antioxidant and antiproliferative capacity of Cyperus rotundus products towards K562 erythroleukemia cells. Chem. Biol. Interact. 2009, 181:85-94.
19. Lee C.H., Hwang D.S., Kim H.G., Oh H., Park H., Cho J.H., Lee J.M., Jang J.B., Lee K.S., Oh M.S. Protective effect of Cyperi rhizoma against 6-hydroxydopamine- induced neuronal damage. J. Med. Food 2010, 13:564-571.
20. Levy D.E., Caronna J.J., Singer B.H., Lipinski R.H., Frydman H., Plum F. Predicting outcome from hypoxic-ischemic coma. JAMA 1985, 253:1420-1426.
21. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
22. Lister J. Ethologically based animal models of anxiety disorders. Pharmacol. Ther. 1990, 46:321-340.
23. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 1987, 92:180-185.
24. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
25. Lowry O.H., Rosenborough N.J., Farr A.L., Randal R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
26. Margaill I., Plotkine M., Lerouet D. Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 2005, 39:429-443.
27. Mergenthaler P., Dirnagl U., Meisel A. Pathophysiology of stroke: lessons from animal models. Metab. Brain Dis. 2004, 19:151-167.
28. Newburger J.W., Jonas R.A., Wemovsky G., Wypij D., Kickey P.R., Kuban K.C.K., Farrell D.M., Holmes C.L., Helmers S.L., Constantinou J., et al. A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N. Engl. J. Med. 1993, 329:1057-1064.
29. Nicholls D.G., Budd L.S. Neuronal exicitoxicity: the role of mitochondira. Biofactors 1998, 8:287-289.
30. Nudo R.J. Mechanisms for recovery of motor function following cortical damage. Curr. Opin. Neurobiol. 2006, 16:638-644.
31. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
32. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association's Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
33. Sadasivam S., Manickam A. Biochemical Methods 2003, Daryaganj, New Delhi. second ed.
34. Schoepp D.D. Novel functions of subtypes of metabotropic glutamate receptors. Neurochem. Int. 1994, 24:439-449.
35. Schroeter H., Bahia P., Spencer J.P.E., Sheppard O., Rattray M., Rice-Evans C., Williams R.J. (-)-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons. J. Neurochem. 2007, 101:1596-1606.
36. Seo W.G., Pae H.O., Oh G.S., Chai K.Y., Kwon T.O., Yun Y.G., Kim N.Y., Chung H.T. Inhibitory effects of methanol extract of Cyperus rotundus rhizomes on nitric oxide and superoxide productions by murine macrophage cell line, RAW 264.7 cells. J. Ethnopharmacol. 2001, 76:59-64.
37. Sharma P.C., Yelne M.B., Dennis T.J. Database on Medicinal Plants used in Ayurveda 2001, Department of Indian System of Medicine, Govt. of India, New Delhi. first ed.
38. Sharp F.R., Lu A., Tang Y., Millhorn D.E. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2000, 20:1011-1032.
39. Sonwa M.M., Konig W.A. Chemical study of essential oil Cyperus rotundus. Phytochemistry 2001, 58:799-810.
40. Sovoboda P., Mossinger B. Catecholamines and brain microsomal Na+K+ATPase protection against lipoperoxidative damage. Biochem. Pharmacol. 1981, 30:427-432.
41. Sturm J.W., Donnan G.A., Dewey H.M., Macdonell R.A.L., Gilligan A.K., Srikanth V., Thrift A.G. Quality of life after stroke: the North East Melbourne stroke incidence study (NEMESIS). Stroke 2004, 35:2340-2345.
42. Volpe B.T., Petito C.K. Dementia with bilateral medial temporal lobe ischemia. Neurology 1985, 35:1793-1797.
43. Williams L.S., Ghose S.S., Swindle R.W. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am. J. Psychiatry 2004, 161:1090-1095.
44. Yazdanparast R., Ardestani A. In vitro antioxidant and free radical scavenging activity of Cyperus rotundus. J. Med. Food 2007, 10:667-674.
45. Youdim K.A., Shukitt-Hale B., Joseph J.A. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med. 2004, 37:1683-1693.
46. Zhang Z., Wu R., Li P., Liu F., Zhang W., Zhang P., Li P., Wang Y. Baicalin administration is effective in positive regulation of twenty-four ischemia/reperfusion- related proteins identified by a proteomic study. Neurochem. Int. 2009, 54:488-496.